Study: Children With Alopecia Areata Respond to Tofacitinib Study: Children With Alopecia Areata Respond to Tofacitinib

The chart review summarized the results in 11 pediatric patients, ages 8 to 18 years, all with a diagnosis of alopecia areata, who were treated with tofacitinib.Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology News Source Type: news